<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35457093</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4275</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23084275</ELocationID><Abstract><AbstractText>Many of the survivors of the novel coronavirus disease (COVID-19) are suffering from persistent symptoms, causing significant morbidity and decreasing their quality of life, termed "post-COVID-19 syndrome" or "long COVID". Understanding the mechanisms surrounding PCS is vital to developing the diagnosis, biomarkers, and possible treatments. Here, we describe the prevalence and manifestations of PCS, and similarities with previous SARS epidemics. Furthermore, we look at the molecular mechanisms behind the neurological features of PCS, where we highlight important neural mechanisms that may potentially be involved and pharmacologically targeted, such as glutamate reuptake in astrocytes, the role of NMDA receptors and transporters (EAAT2), ROS signaling, astrogliosis triggered by NF-&#x3ba;B signaling, KNDy neurons, and hypothalamic networks involving Kiss1 (a ligand for the G-protein-coupled receptor 54 (GPR54)), among others. We highlight the possible role of reactive gliosis following SARS-CoV-2 CNS injury, as well as the potential role of the hypothalamus network in PCS manifestations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Mohamed S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala University, 751 24 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala University, 751 24 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsson</LastName><ForeName>J&#xf6;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala University, 751 24 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schi&#xf6;th</LastName><ForeName>Helgi B</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala University, 751 24 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">hypothalamus</Keyword><Keyword MajorTopicYN="N">kisspeptin</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funding source had no role in the design or in the writing of the paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35457093</ArticleId><ArticleId IdType="pmc">PMC9028501</ArticleId><ArticleId IdType="doi">10.3390/ijms23084275</ArticleId><ArticleId IdType="pii">ijms23084275</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baig A.M. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol. 2021;93:2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As Their Numbers Grow, COVID-19 &#x201c;Long Haulers&#x201d; Stump Experts. JAMA. 2020;324:1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID Conditions: Information for Healthcare Providers [Internet]  [(accessed on 21 July 2021)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long COVID in adults discharged from UK hospitals after COVID-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., Ward H., Elliott P. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 doi: 10.1101/2021.06.28.21259452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: Middle aged women face greater risk of debilitating long term symptoms. BMJ. 2021;372:n829. doi: 10.1136/bmj.n829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.S., Moulin T.C., Schi&#xf6;th H.B. Sex differences in COVID-19: The role of androgens in disease severity and progression. Endocrine. 2020;71:3&#x2013;8. doi: 10.1007/s12020-020-02536-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02536-6</ArticleId><ArticleId IdType="pmc">PMC7657570</ArticleId><ArticleId IdType="pubmed">33179220</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. eClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.M., Shang Y.M., Song W.B., Li Q.Q., Xie H., Xu Q.F., Jia J.L., Li L.M., Mao H.L., Zhou X.M., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Solis-Navarro L., Burgos F., Puppo H., Vilar&#xf3; J. Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis. Pulmonology. 2020;27:328&#x2013;337. doi: 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Group for the GAC-19 P-ACS Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Omirah M.A., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int. J. Clin. Pract. 2021;75:e13746. doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., M&#xfc;ller B., Merle U. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin. Infect. Dis. 2021:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Front. Immunol. 2021;12:2574. doi: 10.3389/fimmu.2021.686029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Joynt G.M., Wong K.T., Gomersall C.D., Li T.S., Antonio G., Ko F.W., Chan M.C., Chan D.P., Tong M.W., et al. Impact of severe acute respiratory syndrome [SARS] on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409. doi: 10.1136/thx.2004.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Wong K.T., Ko F.W.S., Tam L.-S., Chan D.P., Woo J., Sung J.J.Y. The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors. Chest. 2005;128:2247&#x2013;2261. doi: 10.1378/chest.128.4.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Das K.M., Lee E.Y., Singh R., Enani M.A., Al Dossari K., Van Gorkom K., Larsson S.G., Langer R.D. Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J. Radiol. Imaging. 2021;27:342&#x2013;349. doi: 10.4103/ijri.IJRI_469_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijri.IJRI_469_16</ArticleId><ArticleId IdType="pmc">PMC5644332</ArticleId><ArticleId IdType="pubmed">29089687</ArticleId></ArticleIdList></Reference><Reference><Citation>Park W.B., Jun K.I., Kim G., Choi J.-P., Rhee J.-Y., Cheon S., Lee C.H., Park J.-S., Kim Y., Joh J.-S., et al. Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. J. Korean Med. Sci. 2018;33:e169. doi: 10.3346/jkms.2018.33.e169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2018.33.e169</ArticleId><ArticleId IdType="pmc">PMC5990444</ArticleId><ArticleId IdType="pubmed">29892209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai J.C., Ko F.W., Ng S.S., TO K.W., Tong M., Hui D.S. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H.B., Wing Y.K., Yu M.W.M., Leung C.M., Ma R.C., Kong A.P., So W.Y., Fong S.Y.Y., Lam S.P. Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors: Long-term Follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Shin H.S., Park H.Y., Kim J.L., Lee J.J., Lee H., Won S.D., Han W. Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors. Psychiatry Investig. 2019;16:59&#x2013;64. doi: 10.30773/pi.2018.10.22.3.</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson K., Skoog E., Jones V., Sandelin L.L., Bj&#xf6;rling C., Fridenstr&#xf6;m E., Edvinsson M., M&#xe5;rtensson A., Olsen B. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure. PLoS ONE. 2021;16:e0247384. doi: 10.1371/journal.pone.0247384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247384</ArticleId><ArticleId IdType="pmc">PMC7971513</ArticleId><ArticleId IdType="pubmed">33735220</ArticleId></ArticleIdList></Reference><Reference><Citation>Comella P.H., Gonzalez-Kozlova E., Kosoy R., Charney A., Peradejordi I., Chandrasekar S., Tyler S., Wang W., Losic B., Zhu J., et al. A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses. medRxiv. 2021 doi: 10.1101/2021.01.29.21250755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.29.21250755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou S.H.Y., Beghi E., Helbok R., Moro E., Sampson J., Altamirano V., Mainali S., Bassetti C., Suarez J.I., McNett M., et al. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19&#x2014;A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw. Open. 2021;4:e2112131. doi: 10.1001/jamanetworkopen.2021.12131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.12131</ArticleId><ArticleId IdType="pmc">PMC8114143</ArticleId><ArticleId IdType="pubmed">33974053</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer&#x2019;s Res. Ther. 2020;12:69. doi: 10.1186/s13195-020-00640-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A., Mohamed M.S., Moulin T.C., Schi&#xf6;th H.B. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J. Neuroimmunol. 2021;358:577658. doi: 10.1016/j.jneuroim.2021.577658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577658</ArticleId><ArticleId IdType="pmc">PMC8272134</ArticleId><ArticleId IdType="pubmed">34304141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel J., Lampe J., M&#xfc;ller-Fielitz H., Schuster R., Zille M., M&#xfc;ller K., Krohn M., K&#xf6;rbelin J., Zhang L., &#xd6;zorhan &#xdc;., et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat. Neurosci. 2021;24:1522&#x2013;1533. doi: 10.1038/s41593-021-00926-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00926-1</ArticleId><ArticleId IdType="pmc">PMC8553622</ArticleId><ArticleId IdType="pubmed">34675436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood&#x2013;brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2020;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., von Bartheld C.S., Butowt R. Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19. Front. Cell. Neurosci. 2021;15:674123. doi: 10.3389/fncel.2021.674123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.674123</ArticleId><ArticleId IdType="pmc">PMC8287262</ArticleId><ArticleId IdType="pubmed">34290590</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank M.G., Nguyen K.H., Ball J.B., Hopkins S., Kelley T., Baratta M.V., Fleshner M., Maier S.F. SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties. Brain Behav. Immun. 2022;100:267&#x2013;277. doi: 10.1016/j.bbi.2021.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.007</ArticleId><ArticleId IdType="pmc">PMC8667429</ArticleId><ArticleId IdType="pubmed">34915155</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F., Carregari V.C., Veras F.P., Vendramini P.H., Valen&#xe7;a A.G.F., Antunes A.S.L.M., Brand&#xe3;o-Teles C., da Silva Zuccoli G., Reis-de-Oliveira G., Silva-Costa L.C., et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. medRxiv. 2020:16. doi: 10.1101/2020.10.09.20207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J., N&#xe4;&#xe4;s A., F&#xe4;llmar D., Cunningham J.L., Klang A., Ashton N.J., Jackmann S., Westman G., Frithiof R., Blennow K., et al. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity. Eur. J. Neurol. 2020;28:3324&#x2013;3331. doi: 10.1111/ene.14703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14703</ArticleId><ArticleId IdType="pmc">PMC8518988</ArticleId><ArticleId IdType="pubmed">33369818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Ashton N.J., Andersson L.-M., Yilmaz A., Lindh M., Nilsson S., Price R.W., Blennow K., Zetterberg H., Gissl&#xe9;n M. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95:e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular Injury in the Brains of Patients with COVID-19. N. Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tav&#x10d;ar P., Potokar M., Kolenc M., Korva M., Av&#x161;i&#x10d;-&#x17d;upanc T., Zorec R., Jorga&#x10d;evski J. Neurotropic Viruses, Astrocytes, and COVID-19. Front. Cell. Neurosci. 2021;15:123. doi: 10.3389/fncel.2021.662578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.662578</ArticleId><ArticleId IdType="pmc">PMC8062881</ArticleId><ArticleId IdType="pubmed">33897376</ArticleId></ArticleIdList></Reference><Reference><Citation>Schousboe A. Metabolic signaling in the brain and the role of astrocytes in control of glutamate and GABA neurotransmission. Neurosci. Lett. 2019;689:11&#x2013;13. doi: 10.1016/j.neulet.2018.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.01.038</ArticleId><ArticleId IdType="pubmed">29378296</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pitt&#xe0; M., Brunel N., Volterra A. Astrocytes: Orchestrating synaptic plasticity? Neuroscience. 2016;323:43&#x2013;61. doi: 10.1016/j.neuroscience.2015.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.04.001</ArticleId><ArticleId IdType="pubmed">25862587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Danbolt N.C. Glutamate as a neurotransmitter in the healthy brain. J. Neural Transm. 2014;121:799. doi: 10.1007/s00702-014-1180-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-014-1180-8</ArticleId><ArticleId IdType="pmc">PMC4133642</ArticleId><ArticleId IdType="pubmed">24578174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K., Lee S.-G., Kegelman T.P., Su Z.-Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., et al. Role of Excitatory Amino Acid Transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J. Cell. Physiol. 2011;226:2484&#x2013;2493. doi: 10.1002/jcp.22609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22609</ArticleId><ArticleId IdType="pmc">PMC3130100</ArticleId><ArticleId IdType="pubmed">21792905</ArticleId></ArticleIdList></Reference><Reference><Citation>Tani H., Dulla C.G., Farzampour Z., Taylor-Weiner A., Huguenard J.R., Reimer R.J. A Local Glutamate-Glutamine Cycle Sustains Synaptic Excitatory Transmitter Release. Neuron. 2014;81:888&#x2013;900. doi: 10.1016/j.neuron.2013.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.026</ArticleId><ArticleId IdType="pmc">PMC4001919</ArticleId><ArticleId IdType="pubmed">24559677</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih A.Y., Erb H., Sun X., Toda S., Kalivas P.W., Murphy T.H. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J. Neurosci. 2006;26:10514&#x2013;10523. doi: 10.1523/JNEUROSCI.3178-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3178-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674710</ArticleId><ArticleId IdType="pubmed">17035536</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran M.M., McFarland K., Melendez R.I., Kalivas P.W., Seamans J.K. Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking. J. Neurosci. 2005;25:6389&#x2013;6393. doi: 10.1523/JNEUROSCI.1007-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1007-05.2005</ArticleId><ArticleId IdType="pmc">PMC1413952</ArticleId><ArticleId IdType="pubmed">16000629</ArticleId></ArticleIdList></Reference><Reference><Citation>Saggu R., Schumacher T., Gerich F., Rakers C., Tai K., Delekate A., Petzold G.C. Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia. Acta Neuropathol. Commun. 2016;4:76. doi: 10.1186/s40478-016-0350-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0350-3</ArticleId><ArticleId IdType="pmc">PMC4973061</ArticleId><ArticleId IdType="pubmed">27487766</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Parpura V. Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders. Neurobiol. Dis. 2016;85:254&#x2013;261. doi: 10.1016/j.nbd.2015.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.03.025</ArticleId><ArticleId IdType="pmc">PMC4592688</ArticleId><ArticleId IdType="pubmed">25843667</ArticleId></ArticleIdList></Reference><Reference><Citation>Matott M.P., Kline D.D., Hasser E.M. Glial EAAT2 regulation of extracellular nTS glutamate critically controls neuronal activity and cardiorespiratory reflexes. J. Physiol. 2017;595:6045&#x2013;6063. doi: 10.1113/JP274620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP274620</ArticleId><ArticleId IdType="pmc">PMC5577520</ArticleId><ArticleId IdType="pubmed">28677303</ArticleId></ArticleIdList></Reference><Reference><Citation>Dringen R., Brandmann M., Hohnholt M.C., Blumrich E.-M. Glutathione-Dependent Detoxification Processes in Astrocytes. Neurochem. Res. 2014;40:2570&#x2013;2582. doi: 10.1007/s11064-014-1481-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-014-1481-1</ArticleId><ArticleId IdType="pubmed">25428182</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckingham S.C., Campbell S.L., Haas B.R., Montana V., Robel S., Ogunrinu T., Sontheimer H. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 2011;17:1269&#x2013;1274. doi: 10.1038/nm.2453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2453</ArticleId><ArticleId IdType="pmc">PMC3192231</ArticleId><ArticleId IdType="pubmed">21909104</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria F.N., P&#xe9;rez-Samart&#xed;n A., Martin A., Gona K.B., Llop J., Szczupak B., Chara J.C., Matute C., Domercq M. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J. Clin. Investig. 2014;124:3645&#x2013;3655. doi: 10.1172/JCI71886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71886</ArticleId><ArticleId IdType="pmc">PMC4109556</ArticleId><ArticleId IdType="pubmed">25036707</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal A., Vidos C., Monteverde Busso M., Cieri M.B., Ramos A.J. Pathological Neuroinflammatory Conversion of Reactive Astrocytes Is Induced by Microglia and Involves Chromatin Remodeling. Front. Pharmacol. 2021;12:1448. doi: 10.3389/fphar.2021.689346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.689346</ArticleId><ArticleId IdType="pmc">PMC8255379</ArticleId><ArticleId IdType="pubmed">34234677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro D.E., Oliveira-Giacomelli &#xc1;., Glaser T., Arnaud-Sampaio V.F., Andrejew R., Dieckmann L., Baranova J., Lameu C., Ratajczak M.Z., Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol. Psychiatry. 2020;26:1044&#x2013;1059. doi: 10.1038/s41380-020-00965-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00965-3</ArticleId><ArticleId IdType="pmc">PMC7738776</ArticleId><ArticleId IdType="pubmed">33328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo E.-K., Kim J.K., Shin D.-M., Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 2016;13:148&#x2013;159. doi: 10.1038/cmi.2015.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2015.95</ArticleId><ArticleId IdType="pmc">PMC4786634</ArticleId><ArticleId IdType="pubmed">26549800</ArticleId></ArticleIdList></Reference><Reference><Citation>John G.R., Simpson J.E., Woodroofe M.N., Lee S.C., Brosnan C.F. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: Implications for inflammatory gene expression. J. Neurosci. 2001;21:4134&#x2013;4142. doi: 10.1523/JNEUROSCI.21-12-04134.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-12-04134.2001</ArticleId><ArticleId IdType="pmc">PMC6762769</ArticleId><ArticleId IdType="pubmed">11404398</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman M., Irwin M.R. Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far. Brain Behav. Immun. 2020;83:7&#x2013;21. doi: 10.1016/j.bbi.2019.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.09.016</ArticleId><ArticleId IdType="pmc">PMC6940145</ArticleId><ArticleId IdType="pubmed">31550500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Steinbeis F., Haffke M., Gordon R., Heidecker B., Volk H.D., Skurk C., et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome [ME/CFS] following the first pandemic wave in Germany&#x2014;A first analysis of a prospective observational study. medRxiv. 2021 doi: 10.1101/2021.02.06.21249256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda M., Ifuku M., Hossain M.S., Katafuchi T. Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome. Front. Psychiatry. 2018;9:589. doi: 10.3389/fpsyt.2018.00589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00589</ArticleId><ArticleId IdType="pmc">PMC6250825</ArticleId><ArticleId IdType="pubmed">30505285</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L.R., Crouch B., Kwiatek R., Burnet R., Mernone A., Chryssidis S., Scroop G., Del Fante P. A brain MRI study of chronic fatigue syndrome: Evidence of brainstem dysfunction and altered homeostasis. NMR Biomed. 2011;24:1302&#x2013;1312. doi: 10.1002/nbm.1692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1692</ArticleId><ArticleId IdType="pmc">PMC4369126</ArticleId><ArticleId IdType="pubmed">21560176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., George S.Z., Clauw D.J., Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Kosek E., Ickmans K., Fern&#xe1;ndez-Carnero J., Polli A., Kapreli E., Huysmans E., et al. Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021;3:e383&#x2013;e392. doi: 10.1016/S2665-9913(21)00032-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00032-1</ArticleId><ArticleId IdType="pubmed">38279393</ArticleId></ArticleIdList></Reference><Reference><Citation>Druce K.L., McBeth J. Central sensitization predicts greater fatigue independently of musculoskeletal pain. Rheumatology. 2019;58:1923&#x2013;1927. doi: 10.1093/rheumatology/kez028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kez028</ArticleId><ArticleId IdType="pmc">PMC6812719</ArticleId><ArticleId IdType="pubmed">30815696</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M., Nijs J. Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin. Rheumatol. 2006;26:465&#x2013;473. doi: 10.1007/s10067-006-0433-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-006-0433-9</ArticleId><ArticleId IdType="pmc">PMC1820749</ArticleId><ArticleId IdType="pubmed">17115100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., Meeus M., Van Oosterwijck J., Ickmans K., Moorkens G., Hans G., De Clerck L.S. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur. J. Clin. Investig. 2012;42:203&#x2013;212. doi: 10.1111/j.1365-2362.2011.02575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2011.02575.x</ArticleId><ArticleId IdType="pubmed">21793823</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Liang J., Wang J., Fei Z., Qin G., Zhang D., Zhou J., Chen L. Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine. J. Neurochem. 2020;155:370&#x2013;389. doi: 10.1111/jnc.14944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14944</ArticleId><ArticleId IdType="pubmed">31872442</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J., Bair M., Descalzi G. Reactive Astrocytes: Critical Players in the Development of Chronic Pain. Front. Psychiatry. 2021;12:809. doi: 10.3389/fpsyt.2021.682056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.682056</ArticleId><ArticleId IdType="pmc">PMC8192827</ArticleId><ArticleId IdType="pubmed">34122194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji R.R., Berta T., Nedergaard M. Glia and pain: Is chronic pain a gliopathy? Pain. 2013;154((Suppl. S1)):S10&#x2013;S28. doi: 10.1016/j.pain.2013.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2013.06.022</ArticleId><ArticleId IdType="pmc">PMC3858488</ArticleId><ArticleId IdType="pubmed">23792284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., Yalcin B., Taylor K.R., Dutton S., Acosta-Alvarez L., et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022 doi: 10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Simr&#xe9;n J., Ed&#xe9;n A., Andersson L.-M., Nilsson S., Ashton N.J., Sundvall P.-D., Nellg&#xe5;rd B., Blennow K., Zetterberg H., et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. eBioMedicine. 2021;70:103512. doi: 10.1016/j.ebiom.2021.103512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovannoni F., Quintana F.J. The Role of Astrocytes in CNS Inflammation. Trends Immunol. 2020;41:805&#x2013;819. doi: 10.1016/j.it.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC8284746</ArticleId><ArticleId IdType="pubmed">32800705</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Meunier N., Bryche B., von Bartheld C.S. The olfactory nerve is not a likely route to brain infection in COVID-19: A critical review of data from humans and animal models. Acta Neuropathol. 2021;141:809&#x2013;822. doi: 10.1007/s00401-021-02314-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02314-2</ArticleId><ArticleId IdType="pmc">PMC8075028</ArticleId><ArticleId IdType="pubmed">33903954</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., B&#xe9;cavin C., Berg M., Queen R., Litvinukova M., Talavera-L&#xf3;pez C., Maatz H., Reichart D., Sampaziotis F., et al. {SARS}-{CoV}-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonne J., Lopez-Ojeda W. Neuroanatomy, Cranial Nerve. StatPearls; Treasure Island, FL, USA: Nov 19, 2020.</Citation></Reference><Reference><Citation>Pineda A.G., Leon-Sarmiento F.E., Doty R.L. Cranial nerve 13. Handb. Clin. Neurol. 2019;164:135&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">31604543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nampoothiri S., Sauve F., Ternier G., Fernandois D., Coelho C., Imbernon M., Deligia E., Perbet R., Florent V., Baroncini M., et al. The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis. bioRxiv. 2020 doi: 10.1101/2020.06.08.139329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.08.139329</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwanzel-Fukuda M., Morrell J.I., Pfaff D.W. Ontogenesis of neurons producing luteinizing hormone-releasing hormone (LHRH) in the nervus terminalis of the rat. J. Comp. Neurol. 1985;238:348&#x2013;364. doi: 10.1002/cne.902380309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.902380309</ArticleId><ArticleId IdType="pubmed">3900152</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwanzel-Fukuda M. Origin and migration of luteinizing hormone-releasing hormone neurons in mammals. Microsc. Res. Tech. 1999;44:2&#x2013;10. doi: 10.1002/(SICI)1097-0029(19990101)44:1&lt;2::AID-JEMT2&gt;3.0.CO;2-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0029(19990101)44:1&lt;2::AID-JEMT2&gt;3.0.CO;2-4</ArticleId><ArticleId IdType="pubmed">9915559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirsig-Wiechmann C.R., Wiechmann A.F., Eisthen H.L. What defines the nervus terminalis? Neurochemical, developmental, and anatomical criteria. Prog. Brain Res. 2002;141:45&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12508560</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.-J., Shan Y., Whittington N.C., Wray S. Nasal Placode Development, GnRH Neuronal Migration and Kallmann Syndrome. Front. Cell Dev. Biol. 2019;7:121. doi: 10.3389/fcell.2019.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00121</ArticleId><ArticleId IdType="pmc">PMC6637222</ArticleId><ArticleId IdType="pubmed">31355196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman M.N., Merkley C.M., Coolen L.M., Goodman R.L. Anatomy of the kisspeptin neural network in mammals. Brain Res. 2010;1364:90&#x2013;102. doi: 10.1016/j.brainres.2010.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.09.020</ArticleId><ArticleId IdType="pmc">PMC2992597</ArticleId><ArticleId IdType="pubmed">20858464</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonne J., Reddy V., Lopez-Ojeda W. Neuroanatomy, Cranial Nerve 0 [Terminal Nerve] StatPearls; Treasure Island, FL, USA: Feb 24, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">29083731</ArticleId></ArticleIdList></Reference><Reference><Citation>Skorupskaite K., George J.T., Anderson R.A. The kisspeptin-GnRH pathway in human reproductive health and disease. Hum. Reprod Update. 2014;20:485. doi: 10.1093/humupd/dmu009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/humupd/dmu009</ArticleId><ArticleId IdType="pmc">PMC4063702</ArticleId><ArticleId IdType="pubmed">24615662</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla S.L., Perez J.G., Ben-Hamo M., Johnson C.W., Sanchez R.E., Bussi I.L., Palmiter R.D., Horacio O. Kisspeptin Neurons in the Arcuate Nucleus of the Hypothalamus Orchestrate Circadian Rhythms and Metabolism. Curr. Biol. 2019;29:592&#x2013;604.e4. doi: 10.1016/j.cub.2019.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2019.01.022</ArticleId><ArticleId IdType="pmc">PMC7147454</ArticleId><ArticleId IdType="pubmed">30744968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman-Smith M.A., Williams H., Krajewski-Hall S.J., McMullen N.T., Rance N.E. Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc. Natl. Acad. Sci. USA. 2012;109:19846&#x2013;19851. doi: 10.1073/pnas.1211517109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1211517109</ArticleId><ArticleId IdType="pmc">PMC3511761</ArticleId><ArticleId IdType="pubmed">23150555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rance N.E., Dacks P.A., Mittelman-Smith M.A., Romanovsky A.A., Krajewski-Hall S.J. Modulation of body temperature and LH secretion by hypothalamic KNDy [kisspeptin, neurokinin B and dynorphin] neurons: A novel hypothesis on the mechanism of hot flushes. Front. Neuroendocrinol. 2013;34:211&#x2013;227. doi: 10.1016/j.yfrne.2013.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2013.07.003</ArticleId><ArticleId IdType="pmc">PMC3833827</ArticleId><ArticleId IdType="pubmed">23872331</ArticleId></ArticleIdList></Reference><Reference><Citation>De Roux N., Genin E., Carel J.C., Matsuda F., Chaussain J.L., Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl. Acad. Sci. USA. 2003;100:10972. doi: 10.1073/pnas.1834399100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1834399100</ArticleId><ArticleId IdType="pmc">PMC196911</ArticleId><ArticleId IdType="pubmed">12944565</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbara A., Clarke S.A., Dhillo W.S. Clinical Potential of Kisspeptin in Reproductive Health. Trends Mol. Med. 2021;27:807&#x2013;823. doi: 10.1016/j.molmed.2021.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.05.008</ArticleId><ArticleId IdType="pubmed">34210598</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Yeo S.H., McQuillan H.J., Herde M.K., Hessler S., Cheong I., Porteous R., Herbison A.E. Highly redundant neuropeptide volume co-transmission underlying episodic activation of the gnrh neuron dendron. eLife. 2021;10:e62455. doi: 10.7554/eLife.62455.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.62455</ArticleId><ArticleId IdType="pmc">PMC7847305</ArticleId><ArticleId IdType="pubmed">33464205</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelman-Smith M.A., Williams H., Krajewski-Hall S.J., Lai J., Ciofi P., McMullen N.T., Rance N.E. Arcuate Kisspeptin/Neurokinin B/Dynorphin (KNDy) Neurons Mediate the Estrogen Suppression of Gonadotropin Secretion and Body Weight. Endocrinology. 2012;153:2800&#x2013;2812. doi: 10.1210/en.2012-1045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2012-1045</ArticleId><ArticleId IdType="pmc">PMC3359616</ArticleId><ArticleId IdType="pubmed">22508514</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.T., Cunningham M.J., Rissman E.F., Clifton D.K., Steiner R.A. Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology. 2005;146:3686&#x2013;3692. doi: 10.1210/en.2005-0488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2005-0488</ArticleId><ArticleId IdType="pubmed">15919741</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J.T., Popa S.M., Clifton D.K., Hoffman G.E., Steiner R.A. Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J. Neurosci. 2006;26:6687&#x2013;6694. doi: 10.1523/JNEUROSCI.1618-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1618-06.2006</ArticleId><ArticleId IdType="pmc">PMC6673844</ArticleId><ArticleId IdType="pubmed">16793876</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan J.A., Singhal G., Corrigan F., Jaehne E.J., Jawahar M.C., Breen J., Pederson S., Baune B.T. Ceasing exercise induces depression-like, anxiety-like, and impaired cognitive-like behaviours and altered hippocampal gene expression. Brain Res. Bull. 2019;148:118&#x2013;130. doi: 10.1016/j.brainresbull.2019.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2019.02.014</ArticleId><ArticleId IdType="pubmed">30826395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Xie W., Li D., Shi L., Ye G., Mao Y., Xiong Y., Sun H., Zheng F., Chen Z. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J. Med. Virol. 2021;93:456&#x2013;462. doi: 10.1002/jmv.26259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26259</ArticleId><ArticleId IdType="pmc">PMC7361404</ArticleId><ArticleId IdType="pubmed">32621617</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;ayan S., U&#x11f;uz M., Saylam B., Akbay E. Effect of serum total testosterone and its relationship with other laboratory parameters on the prognosis of coronavirus disease 2019 [COVID-19] in SARS-CoV-2 infected male patients: A cohort study. Aging Male. 2020;23:1493&#x2013;1503. doi: 10.1080/13685538.2020.1807930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13685538.2020.1807930</ArticleId><ArticleId IdType="pubmed">32883151</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj K., Ravichandran S., Krishnan S., Radhakrishnan R.K., Manickam N., Kandasamy M. Testicular Atrophy and Hypothalamic Pathology in COVID-19: Possibility of the Incidence of Male Infertility and HPG Axis Abnormalities. Reprod. Sci. 2021;28:2735&#x2013;2742. doi: 10.1007/s43032-020-00441-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-020-00441-x</ArticleId><ArticleId IdType="pmc">PMC7790483</ArticleId><ArticleId IdType="pubmed">33415647</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta P., Dutta S. COVID-19 and hypogonadism: Secondary immune responses rule-over endocrine mechanisms. Hum. Fertil. 2021. ahead-of-print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14647273.2020.1867902</ArticleId><ArticleId IdType="pubmed">33439057</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani A.S., Mukhtar N., Aljomaiah A., Aljamei H., Bakhsh A., Alsudani N., Elsayed T., Alrashidi N., Fadel R., Alqahtani E., et al. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocr. Pract. 2021;27:83&#x2013;89. doi: 10.1016/j.eprac.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer C., Acosta-Martinez M., Dubois S.L., Wolfe A., Radovick S., Boehm U., Levine J.E. Timing and completion of puberty in female mice depend on estrogen receptor alpha-signaling in kisspeptin neurons. Proc. Natl. Acad. Sci. USA. 2010;107:22693&#x2013;22698. doi: 10.1073/pnas.1012406108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1012406108</ArticleId><ArticleId IdType="pmc">PMC3012491</ArticleId><ArticleId IdType="pubmed">21149719</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T., Zhang J., Wang T., Cui P., Chen Z., Jiang J., Zhou S., Dai J., Wang B., Yuan S., et al. Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China. Clin. Infect. Dis. 2021;72:e240&#x2013;e248. doi: 10.1093/cid/ciaa1022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1022</ArticleId><ArticleId IdType="pmc">PMC7454316</ArticleId><ArticleId IdType="pubmed">32697835</ArticleId></ArticleIdList></Reference><Reference><Citation>Newson L., Lewis R., O&#x2019;Hara M. Long Covid and menopause&#x2014;The important role of hormones in Long Covid must be considered. Maturitas. 2021;152:74. doi: 10.1016/j.maturitas.2021.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2021.08.026</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021 [Internet] 2021.  [(accessed on 1 November 2021)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Jayasena C.N., Comninos A.N., Stefanopoulou E., Buckley A., Narayanaswamy S., Izzi-Engbeaya C., Abbara A., Ratnasabapathy R., Mogford J., Ng N., et al. Neurokinin B administration induces hot flushes in women. Sci. Rep. 2015;5:8466. doi: 10.1038/srep08466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08466</ArticleId><ArticleId IdType="pmc">PMC4329553</ArticleId><ArticleId IdType="pubmed">25683060</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi M., Dhillo W.S. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes. Neuroendocrinology. 2019;109:242&#x2013;248. doi: 10.1159/000495889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495889</ArticleId><ArticleId IdType="pubmed">30504731</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R., Riste L., Hann M., Walther A., Mukherjee A., Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med. Hypotheses. 2020;144:110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A., Furlanis G., Frezza N.A., Valentinotti R., Ajcevic M., Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: A prospective multidomain observational study. J. Neurol. 2021;269:587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2021;21:e63. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson A.V., Latchford K.J., Samson W.K. The paraventricular nucleus of the hypothalamus&#x2014;A potential target for integrative treatment of autonomic dysfunction. Expert Opin. Ther. Targets. 2008;12:717&#x2013;727. doi: 10.1517/14728222.12.6.717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.12.6.717</ArticleId><ArticleId IdType="pmc">PMC2682920</ArticleId><ArticleId IdType="pubmed">18479218</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayan E., Sklerov M., Browner N. Disrupted hypothalamic functional connectivity in patients with PD and autonomic dysfunction. Neurology. 2018;90:e2051&#x2013;e2058. doi: 10.1212/WNL.0000000000005641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005641</ArticleId><ArticleId IdType="pubmed">29728527</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A Paradigm for Post-COVID-19 Fatigue Syndrome Analogous to ME/CFS. Front. Neurol. 2021;12:701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>